Stockreport

Aura Biosciences to Participate in Upcoming Investor Conferences

Aura Biosciences, Inc.  (AURA) 
PDF BOSTON--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) the [Read more]